Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Active, not recruitingPhase 3 治疗更年期综合征(肾阴阳两虚证)有效性、安全性的随机、双盲、安慰剂对照、多中心的III期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial of efficacy and safety in the treatment of menopausal syndrome (kidney yin and yang deficiency syndrome)
评价本品治疗更年期综合征(肾阴阳两虚证)的有效性和安全性。
[Translation] To evaluate the efficacy and safety of this product in the treatment of menopausal syndrome (kidney yin and yang deficiency syndrome).
/ Not yet recruitingNot Applicable [Translation] Study on the bioequivalence of amoxicillin capsules in healthy volunteers
本试验旨在研究单次空腹和餐后口服湖南安邦制药有限公司研制、生产的阿莫西林胶囊(0.25 g)的药代动力学特征;以LTLファーマ株式会社生产的阿莫西林胶囊(Sawacillin®,250 mg)为参比制剂,比较两制剂中药动学参数Cmax、AUC0-t、AUC0-∞,评价两制剂的人体生物等效性。
[Translation] The purpose of this study was to study the pharmacokinetic characteristics of amoxicillin capsules (0.25 g) developed and produced by Hunan Anbang Pharmaceutical Co., Ltd. after single fasting and postprandial oral administration; using amoxicillin capsules (Sawacillin®, 250 mg) produced by LTL Pharmaceutical Co., Ltd. as the reference preparation, the pharmacokinetic parameters Cmax, AUC0-t, and AUC0-∞ of the two preparations were compared, and the bioequivalence of the two preparations in humans was evaluated.
100 Clinical Results associated with Hunan Anbang Pharmaceuticals Co. Ltd.
0 Patents (Medical) associated with Hunan Anbang Pharmaceuticals Co. Ltd.
100 Deals associated with Hunan Anbang Pharmaceuticals Co. Ltd.
100 Translational Medicine associated with Hunan Anbang Pharmaceuticals Co. Ltd.